Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$25.41
+5.92%
Mkt Cap $1.58B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $30.00 – $56.00
Implied Upside
+81.0%
Consensus $46.00 vs current $25.41
NASDAQ·Healthcare·Biotechnology
$25.41
+5.92%
Mkt Cap $1.58B
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $30.00 – $56.00
+81.0%
Consensus $46.00 vs current $25.41